These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6882626)
21. Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid. Nishida T; Miwa H; Yamamoto M; Koga T; Yao T Gut; 1982 Sep; 23(9):751-7. PubMed ID: 7106622 [TBL] [Abstract][Full Text] [Related]
22. Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Hamilton I; Cobden I; Rothwell J; Axon AT Gut; 1982 Mar; 23(3):202-10. PubMed ID: 6802711 [TBL] [Abstract][Full Text] [Related]
23. Assessment of hypolactasia and site-specific intestinal permeability by differential sugar absorption of raffinose, lactose, sucrose and mannitol. Hessels J; Eidhof HH; Steggink J; Roeloffzen WW; Wu K; Tan G; van de Stadt J; van Bergeijk L Clin Chem Lab Med; 2003 Aug; 41(8):1056-63. PubMed ID: 12964814 [TBL] [Abstract][Full Text] [Related]
24. [Measurement of selective intestinal permeability using a new, simple sugar absorption test]. van Elburg RM; Kokke FT; Uil JJ; Mulder CJ; de Monchy JG; Heymans HS Ned Tijdschr Geneeskd; 1993 Oct; 137(41):2091-5. PubMed ID: 8413731 [TBL] [Abstract][Full Text] [Related]
25. The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects. Au WY; Dring LG; Grahame-Smith DG; Isaac P; Williams RT Biochem J; 1972 Aug; 129(1):1-10. PubMed ID: 4646774 [TBL] [Abstract][Full Text] [Related]
26. Absorption of inorganic and haemoglobin iron in coeliac disease. Anand BS; Callender ST; Warner GT Br J Haematol; 1977 Nov; 37(3):409-14. PubMed ID: 603771 [TBL] [Abstract][Full Text] [Related]
27. Concentration and pH dependency of alpha-methyldopa absorption in rat intestine. Amidon GL; Merfeld AE; Dressman JB J Pharm Pharmacol; 1986 May; 38(5):363-8. PubMed ID: 2872312 [TBL] [Abstract][Full Text] [Related]
28. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester. Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491 [TBL] [Abstract][Full Text] [Related]
29. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate. Campbell N; Paddock V; Sundaram R Clin Pharmacol Ther; 1988 Apr; 43(4):381-6. PubMed ID: 3356082 [TBL] [Abstract][Full Text] [Related]
30. Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease. Melander A; Kahlmeter G; Kamme C; Ursing B Eur J Clin Pharmacol; 1977 Aug; 12(1):69-72. PubMed ID: 332504 [TBL] [Abstract][Full Text] [Related]
31. A study of conjugation and drug elimination in the human neonate. Cummings AJ; Whitelaw AG Br J Clin Pharmacol; 1981 Oct; 12(4):511-5. PubMed ID: 6117307 [TBL] [Abstract][Full Text] [Related]
32. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester. Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238 [TBL] [Abstract][Full Text] [Related]
33. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability. Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020 [TBL] [Abstract][Full Text] [Related]
34. Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn's disease. Cremers SC; van Hogezand R; Bänffer D; den Hartigh J; Vermeij P; Papapoulos SE; Hamdy NA Osteoporos Int; 2005 Dec; 16(12):1727-30. PubMed ID: 15959617 [TBL] [Abstract][Full Text] [Related]
35. Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease. Leonard N; Hourihane DO; Whelan A Gut; 1995 Dec; 37(6):763-5. PubMed ID: 8537045 [TBL] [Abstract][Full Text] [Related]
36. 47Ca studies in adult coeliac disease and other gastrointestinal conditions with particular reference to osteomalacia. Harris OD; Philip HM; Cooke WT; Pover WF Scand J Gastroenterol; 1970; 5(3):169-75. PubMed ID: 4914165 [No Abstract] [Full Text] [Related]
37. Steady-state pharmacokinetics of metronidazole in Crohn's disease. Eradiri O; Jamali F; Thomson AB Biopharm Drug Dispos; 1987; 8(3):249-59. PubMed ID: 3593902 [TBL] [Abstract][Full Text] [Related]
38. Alpha-methyldopa and drug fever. A study of the metabolism of alpha-methyldopa in patients and normal subjects. Valnes K; Hillestad L; Hansen T; Arnold E Acta Med Scand; 1978; 204(1-2):21-5. PubMed ID: 685725 [TBL] [Abstract][Full Text] [Related]
39. Small intestinal plasma cells in coeliac disease. Scott BB; Goodall A; Stephenson P; Jenkins D Gut; 1984 Jan; 25(1):41-6. PubMed ID: 6360813 [TBL] [Abstract][Full Text] [Related]
40. A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy. Jones HM; Cummings AJ; Setchell KD; Lawson AM Br J Clin Pharmacol; 1979 Nov; 8(5):433-40. PubMed ID: 508547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]